Paul Graves Hammerness, MD

Professor (appointment pending), Psychiatry

Paul Hammerness
801 Massachusetts Ave


Expert child psychiatrist, with 20+ years of clinical care, research, teaching, and administrative experience. Experience in behavioral health integration, telemedicine, EHR and inter-departmental collaboration. Uniquely pragmatic, decisive, able to identify next step simple solutions to complex problems. Brings the highest integrity in interactions and standards of clinical care. Mission and culture oriented.

Other Positions

  • Executive Vice Chair, Psychiatry, Boston Medical Center


  • Dartmouth Medical School, MD
  • College of Wooster, BA


  • Published on 9/9/2023

    Albanna A, Soubra K, Alhashmi D, Alloub Z, AlOlama F, Hammerness P, Lakshmanan J, Hechtman L, Hamoda H. Effectiveness of collaborative tele-mental health care for children with attention deficit hyperactivity disorder in United Arab Emirates. East Mediterr Health J. 2023 Sep 09; 29(9):742-748. PMID: 37776136.

    Read at: PubMed
  • Published on 5/11/2022

    Hammerness P, Berger A, Angelini MC, Wilens TE. Cardiovascular Considerations for Stimulant Class Medications. Child Adolesc Psychiatr Clin N Am. 2022 Jul; 31(3):437-448. PMID: 35697394.

    Read at: PubMed
  • Published on 6/4/2021

    Wilens TE, Faraone SV, Hammerness PG, Pliszka SR, Uchida CL, DeSousa NJ, Sallee FR, Incledon B, Newcorn JH. Clinically Meaningful Improvements in Early Morning and Late Afternoon/Evening Functional Impairment in Children with ADHD Treated with Delayed-Release and Extended-Release Methylphenidate. J Atten Disord. 2022 Mar; 26(5):696-705. PMID: 34085581.

    Read at: PubMed
  • Published on 5/1/2021

    Hammerness PG, Cassidy AR, Potts H, Richardson A, Fogler J, Daly KP, Augustyn M. Assessment and Treatment of a Young Adult with Congenital Heart Disease and ADHD. J Dev Behav Pediatr. 2021 05 01; 42(4):340-342. PMID: 33859122.

    Read at: PubMed
  • Published on 2/1/2019

    Partain PI, White J, Hammerness P. New stimulant formulations for pediatric attention-deficit/hyperactivity disorder: a case-based approach for the primary care provider. Curr Opin Pediatr. 2019 Feb; 31(1):166-174. PMID: 30531224.

    Read at: PubMed
  • Published on 1/1/2018

    Hauptman AJ, Acar D, Hammerness P, Fogler JM, Stafford D. A Case of Emotional Trauma in the Setting of Neurodevelopmental Disability. Harv Rev Psychiatry. 2018; 26(6):384-391. PMID: 30407237.

    Read at: PubMed
  • Published on 1/9/2017

    Biederman J, Hammerness P, Sadeh B, Peremen Z, Amit A, Or-Ly H, Stern Y, Reches A, Geva A, Faraone SV. Diagnostic utility of brain activity flow patterns analysis in attention deficit hyperactivity disorder. Psychol Med. 2017 May; 47(7):1259-1270. PMID: 28065167.

    Read at: PubMed
  • Published on 7/28/2016

    Hammerness P, Petty C, Faraone SV, Biederman J. Do Stimulants Reduce the Risk for Alcohol and Substance Use in Youth With ADHD? A Secondary Analysis of a Prospective, 24-Month Open-Label Study of Osmotic-Release Methylphenidate. J Atten Disord. 2017 Jan; 21(1):71-77. PMID: 23264367.

    Read at: PubMed
  • Published on 5/10/2016

    Chan E, Fogler JM, Hammerness PG. Treatment of Attention-Deficit/Hyperactivity Disorder in Adolescents: A Systematic Review. JAMA. 2016 May 10; 315(18):1997-2008. PMID: 27163988.

    Read at: PubMed
  • Published on 3/17/2016

    Sprich SE, Safren SA, Finkelstein D, Remmert JE, Hammerness P. A randomized controlled trial of cognitive behavioral therapy for ADHD in medication-treated adolescents. J Child Psychol Psychiatry. 2016 Nov; 57(11):1218-1226. PMID: 26990084.

    Read at: PubMed

View 79 more publications: View full profile at BUMC

View all profiles